Literature DB >> 15667597

Leishmanicidal activity of edelfosine, miltefosine and ilmofosine.

Samira Azzouz1, Mimoun Maache, Ramon Gil Garcia, Antonio Osuna.   

Abstract

The anti-proliferative action of three alkyl-lysophospholipid derivatives, edelfosine (ET-OCH), miltefosine (Hexadecylphosphocholine), and ilmofosine (BM 14.440) has been studied on the promastigotes and amastigotes of Leishmania donovani. The effect of the three drugs has previously been studied, but the action mode was not clearly elucidated. In this study the effect on the intracellular amastigote forms was evaluated by two different methods: the traditional method, counting the amastigotes within the macrophages stained with Giemsa; and by a new method, staining the nuclear macrophages and amastigotes with ethidium bromide and counting the different population by flow cytometry. This new method, based on the flow cytometry, shows an advantage for evaluating the anti-proliferative effects in intracellular parasites. The ED50 were calculated for the drug activity after 72 hr, and for the three alkyl-lysophospholipid derivatives it were in the range of 26.73-33.31 microM against promastigotes and in the range of 16.46-23.16 against amastigotes. Also, studying the effect against macrophages J774A1, the ED50 were in the range of 24.28-26.38 microM. The effect of the alkyl-lysophospholipids in the macromolecular biosynthesis of the Leishmania donovani, was studied comparing the incorporation of labelled analogues ([3H] thymidine, [3H] uridine and [3H] leucine), respectively, in the DNA, RNA, and proteins of the flagellates treated. Miltefosine was the most active of the alkyl-lysophospholipids, especially in the inhibition of the RNA synthesis. The three compounds studied show high in vitro activity against L. donovani promastigotes and amastigotes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15667597     DOI: 10.1111/j.1742-7843.2005.pto960109.x

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  11 in total

1.  Miltefosine efficiently eliminates Leishmania major amastigotes from infected murine dendritic cells without altering their immune functions.

Authors:  Klaus Griewank; Caroline Gazeau; Andreas Eichhorn; Esther von Stebut
Journal:  Antimicrob Agents Chemother       Date:  2009-12-07       Impact factor: 5.191

2.  In vivo studies of the effectiveness of novel N-halomethylated and non-halomethylated quaternary ammonium salts in the topical treatment of cutaneous leishmaniasis.

Authors:  Maritza Fernandez; Javier Murillo; Luz Amalia Ríos-Vásquez; Rogelio Ocampo-Cardona; David L Cedeño; Marjorie A Jones; Iván D Velez; Sara M Robledo
Journal:  Parasitol Res       Date:  2017-12-11       Impact factor: 2.289

3.  Expression profiling of nuclear receptors in the NCI60 cancer cell panel reveals receptor-drug and receptor-gene interactions.

Authors:  Susan Holbeck; Jianjun Chang; Anne M Best; Angie L Bookout; David J Mangelsdorf; Elisabeth D Martinez
Journal:  Mol Endocrinol       Date:  2010-04-07

4.  In a trial of the use of miltefosine to treat HIV-related cryptosporidiosis in Zambian adults, extreme metabolic disturbances contribute to high mortality.

Authors:  E Sinkala; M Katubulushi; S Sianongo; A Obwaller; P Kelly
Journal:  Ann Trop Med Parasitol       Date:  2011-03

5.  The effect of edelfosine on GRA1 and MIC3 expressions in acute toxoplasmosis.

Authors:  Asal Tanzifi; Amirhosein Khoshi; Saeed Emami; Shahabeddin Sarvi; Mehdi Sharif; Mahbobeh Montazeri; Meysam Moghbeli; Ahmad Daryani
Journal:  Parasitol Res       Date:  2020-01-22       Impact factor: 2.289

6.  Treatment failure and miltefosine susceptibility in dermal leishmaniasis caused by Leishmania subgenus Viannia species.

Authors:  Ricardo Obonaga; Olga Lucía Fernández; Liliana Valderrama; Luisa Consuelo Rubiano; Maria Del Mar Castro; Maria Claudia Barrera; Maria Adelaida Gomez; Nancy Gore Saravia
Journal:  Antimicrob Agents Chemother       Date:  2013-10-21       Impact factor: 5.191

7.  Leishmania parasitophorous vacuole membranes display phosphoinositides that create conditions for continuous Akt activation and a target for miltefosine in Leishmania infections.

Authors:  Naixin Zhang; Samiksha Prasad; Charles-Eugene Huyghues Despointes; Jeffrey Young; Peter E Kima
Journal:  Cell Microbiol       Date:  2018-07-31       Impact factor: 3.715

8.  In vitro drug susceptibility of two strains of the wildlife trypanosome, Trypanosoma copemani: A comparison with Trypanosoma cruzi.

Authors:  Adriana Botero; Sarah Keatley; Christopher Peacock; R C Andrew Thompson
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2016-12-23       Impact factor: 4.077

9.  Structurally optimized analogs of the retrograde trafficking inhibitor Retro-2cycl limit Leishmania infections.

Authors:  Evan Craig; Charles-Eugene Huyghues-Despointes; Chun Yu; Emma L Handy; Jason K Sello; Peter E Kima
Journal:  PLoS Negl Trop Dis       Date:  2017-05-15

10.  Eugenia uniflora L. Essential Oil as a Potential Anti-Leishmania Agent: Effects on Leishmania amazonensis and Possible Mechanisms of Action.

Authors:  Klinger Antonio da Franca Rodrigues; Layane Valéria Amorim; Jamylla Mirck Guerra de Oliveira; Clarice Noleto Dias; Denise Fernandes Coutinho Moraes; Eloisa Helena de Aguiar Andrade; Jose Guilherme Soares Maia; Sabrina Maria Portela Carneiro; Fernando Aécio de Amorim Carvalho
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-20       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.